Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

NCT06039280 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: N Acetylcysteine
DRUG: Dexamethasone
OTHER: Placebo

Sponsor

Institute of Liver and Biliary Sciences, India